The gross proceeds to CERo from the offering are expected to be up to $8 million, including $5 million expected to be ...

ARV-393 is Arvinas' investigational PROteolysis TArgeting Chimera (PROTAC) degrader targeting the B-cell lymphoma 6 protein ...

The haematologist-oncologist is continuing his path of helping cancer patients by reducing the costs of one of the most ...

Wisden editor Lawrence Booth delivers his annual take on the state of world cricket At 11.59 on the night of November 30, Jay ...

The spirit of Bergoglio, the Neapolitans and the city have absorbed from the first day of his ascent to Pope: that 'I come ...

Weekly Shonen Jump hit the shelves in Japan and revolutionized manga forever. In the 1990s, it became Japan’s undisputed ...

But former AC Milan coach Capello told La Gazzetta dello Sport: "As if it were a movie. In reality, no, we know very well ...

DT-168 is a GeneTAC® small molecule, formulated as an eye drop, that is designed to selectively target the CTG repeat expansion in the TCF4 gene and reduce the expression of the mutant gene product ...

Not to worry, kid. The duo of Evgeny Kuznetsov and Dylan Strome supplied five helpers each on Ovechkin’s first 17 goals of ...

The quest for more effective cancer radiotherapy continues apace, with Telix Pharmaceuticals (ASX:TLX) today reporting “encouraging” preliminary results from its phase II study to treat recurrent high ...

We are thrilled to welcome Chris to our team at this exciting time for Design, as we advance our portfolio of GeneTAC ® small molecules toward key clinical milestones,” said Pratik Shah, Ph.D., ...

Australia has been good to Race Discrimination Commissioner Giridharan Sivaraman. Born in the subcontinent to an Indian ...